-
1
-
2
Advances in CGRP monoclonal antibodies as migraine therapy: A narrative review
Published 2023-01-01Subjects: Get full text
Article -
3
Erenumab: A novel calcitonin gene-related peptide receptor antagonist developed specifically for migraine prevention
Published 2020-01-01Subjects: “…calcitonin gene-related peptide receptor antagonist…”
Get full text
Article -
4
Calcitonin gene-related peptide (CGRP) receptor antagonists for the acute treatment of migraines in adults
Published 2022-10-01Subjects: “…calcitonin gene-related peptide receptor antagonist…”
Get full text
Article -
5
-
6
Safety of Rimegepant in Adults with Migraine and Cardiovascular Risk Factors: Analysis of a Multicenter, Long-Term, Open-Label Study
Published 2024-07-01Subjects: “…Calcitonin gene-related peptide receptor antagonists…”
Get full text
Article -
7
-
8
It is time anti-CGRP monoclonal antibodies be considered first-line prophylaxis for migraine
Published 2022-08-01Subjects: Get full text
Article -
9
A Scoping Review and Meta-Analysis of Anti-CGRP Monoclonal Antibodies: Predicting Response
Published 2023-06-01Subjects: “…calcitonin gene-related peptide receptor antagonists…”
Get full text
Article -
10
Pediatric Migraines: A Comprehensive Review and Perspectives on Diagnosis and Treatment
Published 2023-05-01Subjects: Get full text
Article